Intravenous Infusions Plc (GHSE:IIL)
Ghana · Delayed Price · Currency is GHS 0.3300
+0.0300 (10.00%)
At close: Jul 14, 2026
Intravenous Infusions Market Cap
Intravenous Infusions has a market cap or net worth of 90.55 million as of July 15, 2026. Its market cap has increased by 343.98% in one year.
Market Cap
90.55M
Enterprise Value
100.30M
Revenue
9.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since December 17, 2015, Intravenous Infusions's market cap has increased from 18.13M to 90.55M, an increase of 399.49%. That is a compound annual growth rate of 16.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 90.55M | 560.00% |
| Dec 4, 2025 | 13.72M | - |
| Dec 22, 2023 | 13.72M | 6.02% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enterprise Group | 1.72B |
| Fan Milk | 1.55B |
| SIC Insurance | 1.17B |
| Trust Bank | 480.00M |
| Cocoa Processing Company | 305.71M |
| Clydestone Ghana | 125.80M |
| Mega African Capital | 51.73M |
| Dannex Ayrton Starwin | 34.75M |